Cyagen Biosciences is a leading Contract Research Organization (CRO) with nearly 20 years of experience, dedicated to accelerating drug discovery and development through the integration of data, algorithms, and advanced modeling techniques. Leveraging our expertise in genetically modified rodent models, we offer comprehensive preclinical services to meet the diverse needs of researchers worldwide. Combining cutting-edge AI technologies with our extensive experience, we provide full-service solutions for target research, virus design and packaging, model construction, and efficacy evaluation. Our mission is to empower researchers across the globe by delivering innovative and intelligent solutions that drive breakthroughs in both fundamental research and drug development.
CUSABIO TECHNOLOGY LLC
CUSABIO Technology is a National High-Tech Enterprise with research, production, and sales in one. After 18 years of effort, CUSABIO has become a good partner to researchers worldwide. We are dedicated to providing 67,000+ validated antibodies, 12,000+ recombinant proteins, 660+ cytokines, and thousands of ELISA kits to global customers in the research fields of cancer, cell biology, immunology, neuroscience, epigenetics, etc. Our products can meet customers’ different demands in various scientific research fields.
Curia Global, Inc
Curia is a global Contract Development and Manufacturing Organization with over 30 years of experience successfully guiding clients through the complexities of drug discovery, development, and manufacturing to make treatments broadly accessible to patients. We offer services across Small Molecules, Generic APIs, and Biologics backed by deep scientific expertise and a robust global network of resources and capabilities. Our dedicated teams, combined with advanced technologies, enable us to be both flexible and scalable, accelerating the delivery of your product to patients. From curiosity to cure, we are your trusted ally, delivering every step to accelerate and sustain life-changing therapeutics. To learn more visit us at curiaglobal.com | Curia is a global CDMO with over 30 years of experience successfully guiding clients through the complexities of drug discovery, development, and manufacturing. Our Biologics services span discovery to clinical manufacturing, including clinical and commercial fill-finish services, for antibodies, recombinant proteins, mRNA therapeutics and many large molecule products. Curia’s expertise and agility deliver a best-in-class experience across discovery, drug substance and drug product development and manufacturing. From curiosity to cure, we are your trusted ally to accelerate life-changing therapeutics. To learn more, visit us at https://curiaglobal.com/biologics/
Crown Bioscience
Crown Bioscience, a JSR Life Sciences company, is a global contract research organization (CRO) dedicated to advancing human health by partnering with biotech and pharmaceutical companies that drive drug discovery and development in oncology and immuno-oncology. We provide a range of integrated solutions, which include preclinical research services, translational platforms, and clinical trial support. Our offer includes the world’s largest commercially available patient-derived xenograft (PDX) collection and over 600 tumor organoid models using Hubrecht Organoid Technology, covering 22 cancer indications. Our expertise extends across a diverse portfolio of platforms and services that utilize in vivo, in vitro, ex vivo, and in silico methods, along with advanced laboratory services that span the entire drug development timeline. Additionally, we maintain an extensive biobank of liquid and human biospecimens, complete with clinical histories. Operating from 11 facilities in the US, Europe, and APAC—including laboratories accredited by the College of American Pathologists (CAP) and the International Organization for Standardization (ISO)—we ensure the highest standards of quality and reliability in our research environments. For more information, please visit www.crownbio.com. | Crown Bioscience, a JSR Life Sciences company, is a global contract research organization (CRO) providing discovery, preclinical and translational platforms to advance oncology, immuno-oncology, and immune-mediated inflammatory diseases. Known for their high quality and expansive in vivo, in vitro and ex vivo preclinical models, they partner with their clients to quantify the efficacy and pharmacological profile of their drug candidate before they move into the clinic. The company is the only preclinical CRO to provide tumor organoid services utilizing HUB technology and has the world’s largest commercially available PDX collection. Additionally, further services available in the areas of high content imaging and a 3D Ex Vivo Patient Tissue Platform, provide greater insights into complex disease pathophysiology. A range of biomarker analysis and applied genomics services are also available to optimize therapeutic benefit. Crown Bioscience helps to deliver superior drug candidates to ensure that patients get the right treatment at the right time. Founded in 2006, Crown Bioscience has nine facilities in the US, Europe, and Asia. Find out more: www.crownbio.com
Creative Biomart Inc
Creative BioMart is a leading biotech company that provides innovative products and services to the scientific community worldwide. We specialize in developing and manufacturing high-quality recombinant proteins, and custom services for life science research, drug discovery, and diagnostic applications. We pride ourselves on our customer-centric approach, which ensures our customers receive exceptional service and support at every stage of their research project. Whether you need any help, our team is always available to help.
Cerba Research
Cerba Research is a global specialty laboratory partner dedicated to advancing oncology drug development. Combining deep scientific expertise with a comprehensive suite of specialty lab solutions including genomics, immunology, histopathology, flow cytometry, and biomarker development. Cerba Research delivers high-quality, actionable insights across the entire clinical trial lifecycle. With integrated specialty and central lab capabilities, advanced technologies, and a strong operational footprint worldwide. Cerba Research empowers pharma and biotech innovators to design smarter studies, unlock complex tumor biology, and accelerate the delivery of new cancer therapies to patients.
Cellecta, Inc.
Cellecta is a trusted provider of functional genomic products and services, offering loss-of-function and gain-of-function CRISPR & RNAi screening, cell barcoding and immune receptor and targeted RNA-Seq expression profiling. We design and manufacture CRISPR, RNAi and cell barcode libraries, kits for immune repertoire and gene expression profiling, lentiviral constructs, and offer cell engineering services for drug target and biomarker discovery.
BioDot
BioDot has provided low-volume dispensing solutions to the Diagnostics, Drug Discovery, and Life Sciences fields since 1994. Our systems deliver accurate microliter-to-picoliter dispensing, enabling laboratories to integrate automation and miniaturization into workflows while maintaining sample integrity and experimental reproducibility. Visit our booth to see our new dynamic platform in operation and explore its applications in modern laboratory workflows.
BioDuro
BioDuro, an Advent International portfolio company is a trusted, leading contract research development, and manufacturing organization (CRDMO) for 30 years. We provide our biotech and pharmaceutical partners with fully integrated services to support their efforts from target identification through to commercial drug product manufacturing. The company is based in the US with operations in China, totaling 2,000+ scientists and 7 global sites across 6 cities. Core expertise includes small and large molecule discovery, development and scale-up, support for IND submission, and unique technology platforms such as bioavailability enhancement of insoluble compounds. The one-stop-shop operation helps biotech and pharma partners across the globe to significantly accelerate discovery and de-risk development to create higher value outcomes. We adhere to one global highest standard of compliance and business operation code. Science-driven, customer-oriented, flexible, people-focused culture enables us to provide top-tier integrated, fast and flexible tailored services to our customers to meet their unique needs and accelerate our development timeline. For more information about BioDuro, please visit our website at www.bioduro-sundia.com | BioDuro, an Advent portfolio company, is a CRDMO with a 30-year proven track record. Headquartered in Irvine, California, BioDuro employs more than 2,000 scientists with deep expertise in small- and large-molecule discovery, development, and manufacturing. We provide fully integrated drug discovery services spanning chemistry, biology, and pharmacokinetics (DMPK), along with comprehensive IND-enabling capabilities, including both drug substance and drug product development.
AURIGENE PHARMACEUTICAL SERVICES LIMITED
Aurigene Pharmaceutical Services Limited is a leading contract research, development, and manufacturing organization (CRO/CDMO) and a long-term partner providing end-to-end solutions thereby accelerating innovation. With a strong legacy of services in discovery chemistry, discovery biology, development and manufacturing we are ideally positioned to serve global pharma and specialty companies worldwide by providing truly integrated services. We handle both small molecule and large-molecule services across various complex technology platforms and niche technologies. We have access to FDA-inspected dedicated R and D centers in India and cGMP sites across India, UK and Mexico. Beyond science, our operations are rooted in the fundamental principles of compliance, information security, quality and sustainability. | Aurigene Pharmaceutical Services is leading contract research, development, and manufacturing organization (CDMO). Built on the legacy of accelerating innovation and backed by a vast experience in drug discovery and development our mission is to relentlessly work for the success of our clients and to build long term relationships through a holistic approach to accelerate the journey of a molecule from laboratory to market. By providing access to our resources, knowledge and experience, we create success for our clients and ultimately patients. We offer integrated and standalone services for medicinal chemistry, biology, preclinical services, DMPK studies, development and manufacturing for clinical phase I-III programs, regulatory submission batches and commercial manufacturing. A differentiating factor is the integrated API and formulations service that spans from key starting material, advanced intermediates, APIs to finished products such as oral solids, sterile products, nasal solutions etc. Our development services in India are complemented by cGMP commercial manufacturing facilities in the UK, Mexico, USA and India.